Back to search

von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.

Data up to Jan 2025

Published1999
Citations11
References35

Total Citations Per Year

Abstract

References (35)

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1980 • 8,534 citations

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

1978 • 4,673 citations

A One-stage Factor VIII (Antihaemophilic Globulin) Assay and its Use on Venous and Capillary Plasma

1962 • 340 citations

Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.

1988 • 244 citations

Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules

1986 • 215 citations

Von Willebrand factor in the vessel wall mediates platelet adherence

1985 • 204 citations

The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII.

1991 • 159 citations

Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition

1984 • 135 citations

Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial

1992 • 115 citations

A sensitive ELISA for von Willebrand factor (vWf:Ag)

1987 • 114 citations

Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading.

1981 • 106 citations

Inter‐individual variation in half‐life of infused recombinant factor VIII is related to pre‐infusion von Willebrand factor antigen levels

1995 • 104 citations

[5] Measurements of platelet interaction with components of the vessel wall in flowing blood

1989 • 91 citations

Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities.

1976 • 90 citations

Characteristics of Various Factor VIII Concentrates used in Treatment of Haemophilia A

1977 • 84 citations

Replacement Therapy with Virus—Inactivated Plasma Concentrates in von Willebrand Disease

1992 • 76 citations

Luminography – an Alternative Assay for Detection of von Willebrand Factor Multimers

1988 • 75 citations

Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions

1986 • 71 citations

Development of a Computer Program to Analyze the Parameters of Platelet-Vessel Wall Interaction

1986 • 67 citations

Further Evidence that Glycoprotein IIb-IIIa Mediates Platelet Spreading on Subendothelium

1991 • 58 citations

A method for measuring plasma ristocetin cofactor activity—normal distribution and stability during storage

1978 • 53 citations

Correction of the bleeding time in treated patients with severe von willebrand disease is not solely dependent on the normal multimeric structure of plasma von willebrand factor

1987 • 51 citations

Therapy of von Willebrand Disease

1993 • 48 citations

The use of intermediate and high purity factor VIII products in the treatment of von Willebrand disease.

1994 • 40 citations

Comparison of the in vitro characteristics of von Willebrand factor in British and commercial factor VIII concentrates

1989 • 36 citations

Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination

1985 • 34 citations

The role of the Baumgartner technique in transfusion medicine: research and clinical applications

1994 • 32 citations

Characterization of von willebrand factor in factor VIII concentrates

1989 • 29 citations

Ex Vivo Models for Studying Thrombosis: Special Emphasis on Shear Rate Dependent Blood-Collagen Interactions

1992 • 26 citations

In vitro and in vivo characterization of a high‐purity, solvent/detergent‐treated factor VIII concentrate: Evidence for its therapeutic efficacy in von Willebrand's disease

1989 • 24 citations

Role for platelet von willebrand factor in supporting platelet‐vessel wall interactions in von willebrand disease

1989 • 19 citations

FACTOR VIII RELATED ACTIVITIES IN CONCENTRATES

1984 • 13 citations

Comparison between Human Umbilical Artery and Rabbit Abdominal Aorta as Substrata for Platelet Adhesion and Platelet Thrombus Formation under Flow Conditions

1991 • 10 citations

An intermediate‐purity factor VIII concentrate supports platelet adhesion under flow conditions

1997 • 6 citations

von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.

1998 • 5 citations

Cited By (0)

Loading...